LIVSEA DS CAPSULES

LIVSEA DS    SYP/CAP/DROPS

ENHANCED FORMULA FOR LIVER PROTECTION FOR ALL AGE GROUP 

LIVSEA DS is well balanced combination of scientifically researched herbs with proven potent hepato protective and hepato regenerative benefits; LIVSEA DS improves liver function parameters in severe liver disorders and ensures protection of hepatocytes from various toxins and viruses. This safeguarding action of LIVSEA DS make it drug of choice for all liver disorders for all age groups.

PUNARNAVA (Boerhavia Diffusa) : has powerful hepato regenerative and anti inflammatory properties.                                                                                                  J.Chem. Pharm. Res., 2010, 2(4):536-545

BHRINGRAJ (Eclipta Alba) : possess hepatoprotective and anti hepatotoxic properties. Effective in treatment of liver cirrhosis, infective hepatitis by reducing centrilobular necrosis.

                                 GJMRP,  2013 7(13) :2249-4618

KALMEGH (Andrographis Paniculata) : diterpenoid content of Kalmegh possess hepatoprotective and hepatocorrective properties and found to be effective in infective hepatitis manifested as jaundice assessed by increased LFT : ALT,ASP SGOT AND SGPT.   

                    Phycog Rev. : Plant Review, Dec 2007 1(2) : 283-298

ARJUNA (Teminalia Arjuna) : flavonoid and Tanin content of bark has hepatoprotective and antioxidant properties.                                                                                      Biochem Pharmacol Feb 2014 3:130

BHUI AMLA (Phylanthus Niruri): alkaloids, in the form of lignins, like phyllanthin and hypophyllanthin possess hepatoprotective and anti viral properties and found to be effective in treatment of different disorders viz; Hepatitis-B, jaundice, cirrhosis of liver, chronic fever, loss of appetite etc. It also helpful in increasing platelets count.

             Journal of Medicinal Plants Studies 2014; 2(6): 50-52

More than 90% of people found satisfactory results and symptomatic relief in disease and found marked improvement in liver function test (LFT) while on treatment with LIVSEA DS.

INDICATIONS :

1. Anaemia in infantile liver disorder
2. Acute and chronic hepatitis due to drug and alcohol
3. Jaundice and viral hepatitis
4. Cirrhosis of liver